analyst
AK
NASDAQ · AKTS
Aktis Oncology, Inc.
Healthcare · Biotechnology
$22.71
Up+$0.30 (+1.34%)
Updated Sep 17, 2026, 4:43 AM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.06B
- P/E ratio
- 0
- Dividend yield
- 0.00%
- 52-week range
- $0.03 – $34.19
- Volume
- 855.05K
- Avg. volume
- 374.39K
Price performance
AKTS price history
1M range · 20 trading sessions · Daily adjusted prices
AKTS closed at $22.71 after 20 trading sessions, down 9.23% for the selected period.
- Last close
- $22.71
- Period change
- -9.23%
- Period low
- $22.41
- Period high
- $27.05
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $22.48 | $22.9428 | $21.31 | $22.71 | 855.05K |
| Sep 15, 2026 | $23.21 | $23.21 | $22.18 | $22.41 | 290.43K |
| Sep 14, 2026 | $23.36 | $23.705 | $22.79 | $23.17 | 330.08K |
| Sep 11, 2026 | $24.36 | $24.54 | $23.25 | $23.30 | 228.58K |
| Sep 10, 2026 | $23.80 | $24.355 | $23.57 | $23.94 | 263.62K |
| Sep 9, 2026 | $25.57 | $26.00 | $24.03 | $24.06 | 377.36K |
| Sep 8, 2026 | $26.99 | $26.99 | $24.23 | $25.02 | 567.43K |
| Sep 4, 2026 | $26.18 | $27.20 | $26.18 | $27.05 | 159.25K |
| Sep 3, 2026 | $27.29 | $27.6633 | $26.08 | $26.65 | 152.78K |
| Sep 2, 2026 | $26.12 | $27.03 | $25.705 | $26.92 | 253.45K |
| Sep 1, 2026 | $25.80 | $26.2025 | $25.1243 | $25.99 | 231.52K |
| Aug 31, 2026 | $25.57 | $26.05 | $25.14 | $25.91 | 213.62K |
| Aug 28, 2026 | $25.96 | $26.80 | $25.52 | $25.78 | 314.65K |
| Aug 27, 2026 | $26.32 | $27.175 | $26.15 | $26.18 | 210.63K |
| Aug 26, 2026 | $26.60 | $26.96 | $25.96 | $26.51 | 257.59K |
| Aug 25, 2026 | $26.30 | $26.89 | $25.4736 | $26.69 | 601.24K |
| Aug 24, 2026 | $24.15 | $26.3055 | $22.955 | $25.98 | 774.58K |
| Aug 21, 2026 | $24.33 | $25.00 | $24.00 | $24.07 | 226.36K |
| Aug 20, 2026 | $24.75 | $24.75 | $23.4374 | $24.00 | 253.62K |
| Aug 19, 2026 | $26.28 | $26.28 | $24.42 | $25.02 | 216.57K |
Latest AKTS news
The latest Smart Investors Daily articles mentioning AKTS.
Stock researchResearch & News · SEC Filings
Loading stock research…